• One of few Canadian cannabis companies to declare dividends
• Poised for first-mover advantage in Canada’s legal marijuana market
• 250 acres of cultivation space spanning from Alberta to Ontario

Retail sales in Canada’s recreational marijuana market could climb to $6.0 billion by 2021, according to Deloitte Canadian, and Invictus MD Strategies Corp. (TSX.V: IMH) (OTC: IVITF) is strategically positioned to grow right alongside this burgeoning market and gain first-mover advantage as soon as Canada’s cannabis market is freed up by the necessary legislative regulations.

Founded in Vancouver, Canada, Invictus MD is a cannabis company that is dedicated to offering high-quality, regulated pharma-grade marijuana for both medical and recreational use using clean and organic production practices. The company represents a platform of licensed cannabis producers located throughout Canada who operate under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The company’s growers are supported by more than 250 acres of production capacity and have total access to Invictus MD’s team of leading horticulturists, biochemists and project managers.

Since its inception, Invictus MD has had its developmental focus on a future time when the marijuana industry will be fully opened into a regulated consumer market. Boosted by legislative progress in Canada, the company has quickly established one of the strongest cultivation profiles in that country, with fully expandable facilities that allow its licensed producers to meet the growing demand for medical cannabis and, soon, for recreational marijuana, as well.

Invictus MD intends to constantly innovate its cultivation process and deploy long-term expansion plans to strengthen its production capacity. In carrying out its strategy for market domination, Invictus MD has completed various shrewd acquisitions that have resulted in huge ROIs (http://dtn.fm/z3Ac6). In all thus far, the company has expended $1.1 million in acquisitions and has gained over $4.1 million in disposals.

Invictus MD stands out among very few Canadian cannabis companies that have declared dividends and is well-positioned to become a leader in the legal cannabis space – not just in Canada but globally.

For more information, visit the company’s website at www.Invictus-MD.com

• First full-service training and career advancement brand in the skilled trades
• Successfully executing a disruptive approach of defragmenting the skilled trades training market
• Positioning itself to become the leading resource of training services and materials for individuals

Providing e-learning and training to promote professional achievement among America’s workers, ProBility Media Corp. (OTCQB: PBYA) is blazing trails as it creates the very first full-service training and career advancement brand in the skilled trades.

Working to change the landscape for small and medium businesses, this EdTech company is engaged in providing consistent, high-quality training materials of a caliber that, typically, only enterprise-level companies would have access to. In offering these topnotch training courses and materials, ProBility is executing a disruptive approach of defragmenting the skilled trades training market and readying the workforce to achieve excellence. ProBility caters to a variety of customers, ranging from tradesmen and small businesses to enterprise-level corporations.

As the gap continues to widen between the skill requirements of hiring companies and the skills possessed by job seekers, companies can have difficulty finding workers that fit their needs, just as would-be workers fail to bring the knowledge and certification needed to qualify for available jobs. ProBility is striving to help craftsmen and skilled workers in the United States obtain the training and expertise they need to successfully compete for available positions within the changing employment landscape. The company’s education and training programs help prepare individuals for a broad range of vocational opportunities, including rigging, craning, plumbing, electrical, and HVAC.

As the professional world sees an increase in occupations that mandate additional education and training, U.S. workers are recognizing that it is necessary to retrain and upgrade their skills in order to compete for the open positions in these fields. ProBility offers a suite of e-learning, technical training and testing solutions and is also seeking to expand those offerings through acquisitions and internal growth. In doing this, the company is positioning itself to become the leading resource of training services and materials for individuals, small and medium businesses and big enterprise customers, providing engineers and tradesmen with an unparalleled assortment of e-learning and training content, exam prep, testing, certification, continuing education and career advancement tools.

For more information, visit the company’s website at www.ProBilityMedia.com

Let us hear your thoughts: ProBility Media Corp. Message Board

• Patent- pending technology to combat active shooter threats
• Cost-effective “smart” protective system
• Large global resellers jump on board

Last month, Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF), developer of the revolutionary award-winning PATSCAN CMR™ concealed weapons detection system, announced two significant reseller agreements with companies that provide security solutions to government, military, health care and commercial organizations. JJB Federal LLC is a veteran-owned information technology communications contracting company, with clients including the U.S. Dept. of the Navy, Dept. of Defense, and the Dept. of Education. Within days, Patriot One announced another reseller agreement with SENGEX, which provides security solutions to government, health care and commercial organizations.

Now, just a month later, Patriot One has announced yet another new reseller agreement, this one with Aotea Security Ltd., which provides New Zealand’s only nationwide solution for electronic security, electrical, fire, and communications services (http://dtn.fm/O4mMJ). Aotea has already garnered meaningful customer interest for the system, and this agreement has opened the door for not only the entire country of New Zealand but also for other sales and agreements throughout the Pacific Rim. This agreement moves Patriot One’s reseller network one step closer to global scale and one step closer to exceeding company goals. In just the three months since product marketing began, orders have been received from locations spanning four continents, and confirmed sales commitments exceed $2.7 million.

Patriot One Technologies, Inc. has developed a disruptive technology to combat active shooter threats before they occur. With the incessant spread of active violence, there’s no doubt of the need for a more sophisticated and efficient protective system for virtually all public venues. In conjunction with McMaster University, Patriot One has created PATSCAN CMR, the first-of-its-kind Cognitive Microwave Radar concealed weapons detection system. The PATSCAN CMR™ is a next generation radar device and custom software solution designed as an effective tool to combat active shooter threats before they occur.

Conventional screening systems only identify the presence of metal objects, not what those objects might be. Identified objects could be belt buckles or keys, and monitoring subways, schools or stadiums becomes extremely difficult. Since current screening systems don’t offer enough precise information to be effective, public places and events are nearly impossible to secure.

Patriot One’s patent-pending system enables stand-off detection, even on moving targets, with the ability to learn, analyze and identify new threats upon deployment. The system actually gets better and smarter at detecting hidden weapons with each screening instance. The technology is able to identify passersby carrying a knife, gun or bomb by analyzing metal content and relating it to a database of known weapon signatures. Built for cost-effective deployment in weapon-restricted buildings and facilities, the Patriot One system can be installed in hallways and doorways to covertly identify weapons and to alert security of an active threat entering the premises.

Patriot One’s latest reseller agreement is an indication of just how much the technology is needed and how rapidly it is being embraced around the world. Active shooter threats have no borders, and this agreement shows the global reach of Patriot One’s technology.

For more information, visit the company’s website at www.Patriot1Tech.com

Let us hear your thoughts: Patriot One Technologies, Inc. Message Board

• Extends loan to May 20, 2021, can take monthly advances up to $1 million
• Proceeds to be used for retirement of debt, general working capital
• North American Transactions segment jumps 40% in leading the way for NETE’s $13.6 million revenues in 1Q17

Net Element, Inc. (NASDAQ: NETE) has successfully converted its $2 million term loan into a $2.5 million revolving loan, which enables NETE and its subsidiaries to take advances of up to $1 million every calendar month. The loan date was also extended to May 20, 2021, from the original date of May 20, 2019.

NETE is a global financial company that supports other firms with a cloud-based system of accepting electronic payments in an omni-channel environment. The company has three segments: North American Transaction Solutions, Mobile Payment Solutions and Online Payment Solutions. A growing percentage of its revenue comes from the North American segment, which generated 78% of total company sales in 2016 and $10,964,919 of NETE’s 1Q17 $13,561,941 revenues. This represented a 40% jump in sales for the North American segment from the prior year. The company attributed the increase to organic growth among its merchants.

In an SEC 8K filing (http://dtn.fm/C9nbd), NETE disclosed that the loan amendment was finalized June 27, 2017, with lender Priority Payment Systems LLC and NETE subsidiaries TOT Payments LLC, TOT New Edge LLC, Process Pink LLC and TOT FBS LLC.

As part of the agreement, NETE agreed to use the proceeds to meet its debt obligations from an acquisition, an ancillary agreement and for working capital. Its obligations under the agreement as of the amendment date totaled $1,925,967, according to the loan.

The company reported revenues of $54.3 million in 2016 and sales for the three months ended March 31, 2017, at $13,561,941, compared to $11,261,059 for the same period of the prior year.

NETE is seeking to generate more revenues in the future by launching a nationwide sales campaign for Aptito, its cloud-based point-of-sale system, with a special $1,200 incentive to agents and dealers per placement. Aptito is designed by NETE as a management tool to increase retention rates and sales productivity in the restaurant and retail industries. It also features a wide array of business management tools.

For more information, visit the company’s website at www.NetElement.com

• Moxian sees its own digital advertising at $3 million in 2017, $6 million in 2018
• Digital advertising at Moxian projected to generate 24% of sales in 2018
• 731 million people in China, more than half of whom use the internet

Moxian, Inc. (NASDAQ: MOXC) is setting a high priority for meeting its revenue goals on digital advertising. According to an AdAge report (http://dtn.fm/K5bnT) quoting WPP’s GroupM research (http://dtn.fm/Vv1s9), such spending in China is skyrocketing to 57.2% of total ad spending on the internet. Five years ago, that number was just 19.4%, per the report. By comparison, only about 30.9% of total ad spending will be digital in the U.S. this year.

Moxian is a digital marketing company which connects online users and merchants with its focus on offline merchants desiring to reach more digitally-oriented customers. Games, rewards and social events are critical to reaching consumers. In return, these merchants can use valuable information learned to promote their products and services at their brick-and-mortar stores in this online-to-offline (O2O) market.

Currently, Moxian is converting its Moxian+ business and user apps from free to paid. Key to Moxian’s revenue stream are fees, subscriptions, licenses and a percentage of all transactions. Vital to this is digital advertising. In the SeeThruEquity research report of February 28, 2017 (http://dtn.fm/0ycOx), mobile advertising is projected by Moxian to reach $3 million in 2017 before doubling to $6 million in 2018. That total would account for 24% of total company sales, it said.

Digital ad spending in China is expected to grow by 21.5% in 2017 compared to its growth of 29.5% last year, albeit on a smaller base. The increase in digital advertising in China is slower, in part, because its sales base has become larger. However, the GroupM report cites “continuing urbanization and solid consumer confidence” as lending optimism for continued overall advertising increases. China had 731 million internet users last year, accounting for more than half the country. That number represents more than double the size of the entire U.S. population.

For more information, visit the company’s website at www.Moxian.com

• Science-based cannabinoid pharmaceuticals are big market winners
• InMed Pharmaceuticals is developing two potential blockbuster drugs
• IMLFF has innovative and disruptive market advantages

The market is rife with hype, pretenders and wannabes in the booming cannabis markets. In the rush to find the next hot cannabis stock, investors often overlook the real value in long-term scientific applications, and, after the heady hoopla of once-illicit marijuana dies down, those that chose science will be the ultimate winners. The medicinal and scientific applications of the 90 individual cannabinoid drugs found in cannabis are where the real value lies. Look no further than GW Pharmaceuticals (NASDAQ: GWPH), an early mover in cannabinoid pharmaceutical development. The company’s shares have exploded from less than $9 in 2013 to around $99 today because of its proven cannabis-based therapies and drug pipeline aimed at treating central nervous system (CNS) and other disorders. Cannabis-based pharmaceutical companies should be recognized as innovative pharmaceutical companies researching the significant benefits of cannabis-based therapeutics.

An extremely interesting innovator in the cannabinoid pharmaceutical space is InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). InMed is a biopharmaceutical company that specializes in developing novel therapies through research into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. The company is currently developing potential blockbuster therapies for glaucoma, one of the leading causes of blindness in the U.S., and epidermolysis bullosa, a devastating genetic skin disease that afflicts up to 20 million newborns in varying degrees of severity. Effective therapeutics for these markets are valued at $5.6 billion and $1 billion, respectively. Blockbuster attributes notwithstanding, the real value drivers for the company can be found in its research and development of the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.

Utilizing its proprietary computer-based bioinformatics assessment tool, InMed’s unique research approach can expedite identification of bioactive compounds that have the potential to significantly impact specific diseases. By using its comprehensive pharmaceutical and cannabinoid structures database, and by creating associations between approved pharmaceuticals and cannabinoids with similar structures, InMed identifies active cannabinoids to act on genes and proteins. Using its comprehensive algorithms and extensive databases, InMed can rapidly scrutinize, analyze and identify novel cannabinoids to determine potential new drug candidates that maximize therapeutic benefit and minimize adverse effects. InMed’s proprietary bioinformatics assessment tool creates immense opportunity for InMed’s rapid identification and development of efficacious cannabinoid therapeutics.

Even more importantly than its bioinformatics assessment tool, InMed is about to disrupt the cannabinoid pharmaceutical sector with its biopharmaceutical approach to the production of pharmaceutical grade, bio-identical cannabinoids. InMed’s biosynthesis process for manufacturing all 90+ naturally occurring cannabinoids will combine the safety, efficacy, convenience, control and quality of a laboratory-based manufacturing process. InMed’s biosynthesis process for manufacturing pharmaceutical cannabinoids could easily become the accepted standard in this new and exciting pharmaceutical arena. InMed is laser focused on the science of cannabinoids, and science, ultimately, always wins.

For more information, visit the company’s website at www.InMedPharma.com

Let us hear your thoughts: InMed Pharmaceuticals, Inc. Message Board

• Commercially developing a covert, disruptive solution using novel radar technology to detect concealed weapons—even on moving targets
• Market’s very first cost-effective answer to active shooter prevention
• Unsurpassed portable system developed through NATO-funded project at McMaster University
• Solution endorsed by Tom Ridge, first secretary of Homeland Security and current advisory board member

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is employing cutting-edge machine learning/artificial intelligence technology in the global fight against terrorism.

The company’s pioneering PATSCAN CMR™, which is the next-generation incarnation of its award-winning NForce CMR1000 software and radar solution, is a disruptive cognitive microwave radar system that is designed to instantly detect concealed weapons, even on moving targets. The system has machine-learning properties that enable it to learn and improve with each deployment and to become more adept at identifying new threats. As a tool in preventing active shooter incidents and other terror attacks, Patriot One’s solution is invaluable.

Patriot One’s patent-pending PATSCAN technology is the first cost-effective solution for active shooter prevention to be offered in the marketplace. Developed at McMaster University through a project funded by NATO, PATSCAN is designed to identify persons who are carrying weapons, such as guns, knives and suicide vests. The system works by analyzing metal content and relating that content to a database of known weapon signatures. This real-time and fully computer-based detection system alerts a facility’s security personnel whenever an active threat is detected, boasting an accuracy rate of 93 percent. The solution is also small, which allows it to be covertly placed in doorways and hallways, scanning those who enter facilities like airports, schools, stadiums and more without them being aware they’re being scanned.

The covertness of PATSCAN eliminates compliance issues, as it scans individuals without their knowledge. It also eradicates the need for human operators, which, in turn, eliminates the shortcomings of human error. Privacy issues are removed, as well, since PATSCAN does not capture an image of the individuals it is scanning. PATSCAN further removes many of the inadequacies of currently used weapons scanning systems, including their time-consuming processes and line-of-sight inadequacies that frequently miss weapons concealed in certain places on the body. PATSCAN’s broad antenna beam instantly illuminates a subject’s entire body, “viewing” the target from various angles for markedly improved detection outcomes.

The key to PATSCAN’s success is halting planned terror events before they can occur through effective prevention technologies and security protocols. Patriot One’s aim is to become a leading provider of such innovative weapons threats countermeasures and to thereby enhance public safety throughout the world.

Considering the high costs of fighting terror—statistics show United States taxpayers spent nearly an estimated $1.7 trillion in war funding between 2001 and 2015—Patriot One is poised to become a huge player in the counterterrorism field and to make a significant positive difference in preventing terrorist actions from taking place.

For more information, visit the company’s website at www.Patriot1Tech.com

Let us hear your thoughts: Patriot One Technologies, Inc. Message Board

• First mover in plant-to-bloodstream niche
• Proprietary technology improving bioavailability of orally ingested cannabinoids
• Two distinct consumer product brands: ViPova™ and Lexaria Energy

With the recreational market set for legalization on July 1, 2018, Canada’s cannabis industry is experiencing a high that is catalyzing innovation in the biosciences sector. Pioneering biopharmaceutical companies there and in other developed countries are working to develop a variety of healthful products based on their research into cannabinoids. As a result, investment capital flow to “plant-to-bloodstream” companies is expected to swell just as it has been doing for “seed-to-plant” companies for some time, and innovative British Columbia-based outfit Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) will, undoubtedly, be buoyed by this development, since it is a “first mover” in this space.

Lexaria is one of that new breed of “plant-to-bloodstream” companies exploring ways to make the health benefits of cannabinoids more accessible. The company has developed technology that delivers the nutriments of hemp oil in a novel and more effective way. Many hemp products on the market are simply mixtures of hemp oil with other ingredients. However, Lexaria’s patented methodology infuses organically sourced hemp oil into the molecules of other substances, such as lipids, which, as it turns out, form the basis of the human endocannabinoid system. Consequently, the body better absorbs products employing the technology.

In general, the human gastrointestinal tract does not handle cannabinoids effectively, and much of what is ingested is simply excreted by the body. In addition, realizing this, many users of edible products will try other cannabinoid delivery methods, such as smoking, with their attendant evils. For those smoking cannabis, there is more peril in the smoking than in the cannabis.

Lexaria applies its innovative delivery technology to its product line, which consists of two distinct brands: ViPova™ and Lexaria Energy. ViPova™ is a delicious Chinese black tea from the province of Yunnan, made from hemp oil-infused within dried evaporated non-fat milk. Introduced in January 2015, the tea is available in a host of varieties and flavors. The ViPova range runs from 8- to 32-bag portions, and varieties include Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light.

If you are a couch potato, Lexaria Energy products are not for you. The Lexaria Energy line is meant for those with busy, active lifestyles. Under this brand, the company has launched a hemp oil-infused protein bar called the Lexaria Energy Bar, which, as its name suggests, provides reserves of energy you can draw on to go the extra mile.

Lexaria is not resting on its laurels with these groundbreaking developments. In February 2017, it signed a master collaborative research agreement with the National Research Council of Canada (NRC) to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions. Lexaria believes its patented technology can be applied to the delivery of nicotine, vitamins, analgesics and a variety of other substances.

In May 2017, the company announced that its 50%-owned joint venture subsidiary, Ambarii Trade Corporation (Ambarii) had entered into a Letter-of-Intent (LOI) with Naturally Splendid Enterprises Ltd. (TSXV: NSP) for the production, sale and distribution of Ambarii’s proprietary sublingual full spectrum hemp CBD tablets in Japan and South Korea. Ambarii CBD Tablets offer a consistent, quick dissolving dose of full spectrum hemp oil, combined with the powerful antioxidant properties of pterostilbene.

Lexaria Bioscience Corp., formerly Lexaria Corp., is a food sciences company. The company focuses on the delivery of cannabinoid compounds procured from legal, agricultural hemp, through gourmet foods based upon its infusion technologies. Its food sciences activities include the development of its nutrient infusion technologies for the production of super foods, and the production of food products under its two consumer product brands, ViPova and Lexaria Energy. Its technology is developed to aid absorption and bioavailability of various payload molecules, including cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC).

For more information, please visit www.lexariaenergy.com

• SING targets the large and rapidly growing multi-billion dollar retail cannabis sales industry
• New agreement provides efficient and easy-to-apply solution to critical unmet need
• Purchasing model opens door to additional opportunities for investor profit in cannabis

An iPod interview with SinglePoint president Wil Ralston (http://dtn.fm/S8exI) covers the significant advantages that the company’s recently announced joint venture with First Bitcoin Capital Corp. (OTC: BITCF) represents for the cannabis industry. In a study of 20 U.S. jurisdictions by Greenwave Advisors, legal marijuana represented $6.5 billion in retail sales by May 2017, as reported by Forbes (http://dtn.fm/3XOmc). At the current level of growth, industry experts project that, by 2021, the legal cannabis retail market may grow to $30 billion. Marijuana is legal in many states for either medicinal and/or recreational purposes. The challenge, therefore, isn’t market reach, but restrictions at the federal level, particularly in the banks. Federal guidelines restrict transactions related to cannabis, but SinglePoint (OTC: SING) has found a way around this by forming its first joint venture – with First Bitcoin Capital Corp. (OTC: BITCF).

The joint venture allows dispensaries and other businesses to use Bitcoin payments rather than traditional cash transactions. This combination of SinglePoint’s acquisition and distribution history and Bitcoin’s payment system and block chain technology is already serving the cannabis industry well. The system is being used to enable customers to visit dispensaries and make purchases using a debit or credit card. The transaction goes through Bitcoin first, with the dollar conversion completed afterward. A streamlined purchasing model is expected to help smooth out the supply chain process, so shareholders and investors in SinglePoint can find additional opportunities to profit and contribute to the fast-growing cannabis industry.

The value of Bitcoin has gone up 236 percent in just one year. It is also recognized as a legal currency in Japan. Being adopted on a wide scale, the technology can also allow SING to reach a global market. In the iPod interview, company president Wil Ralston reveals that there are now 290,000 retail stores in Japan accepting Bitcoin payments. In the U.S., payments can be converted to U.S. currency, according to Ralston, without waiting for the banking system to accept the legal status of cannabis. Ralston said he’s been “waiting for the banks to open up, but we don’t have to wait any longer with this new product. I think this is one of the most exciting things to happen in SinglePoint’s lifespan.”

In addition to a blockchain supply chain management solution, the joint venture is incorporating initial coin offerings through First BitCoin Capital. SinglePoint has also launched SingleSeed.com, which will provide web design and online marketing services to cannabis dispensaries. It’s expected to soon complete a variety of acquisitions as well, leading to anticipated growth in revenue.

The company’s strategy has opened up a vast network of financial and technology partners. This has enabled it to expedite the execution of deliverables. Plus, the cannabis and other high-risk markets don’t have to wait for changes in federal banking guidelines. At the rate Bitcoin payments are catching on, cannabis dispensaries can adopt a point-of-sale solution that allows them to meet growing demand.

In fact, adopting the technology of First Bitcoin Capital and SinglePoint only requires downloading an application onto any point-of-sale machine. Learn more by going to www.SinglePoint.com or www.SingleSeed.com.

Let us hear your thoughts: SinglePoint, Inc. Message Board

• LED lighting producer and leading indoor plant growth solutions provider
• Focused on efficiencies for the legal cannabis industry
• Website is now SEO-optimized, providing an easier way to order product

Future Farm Technologies, Inc. (CSE: FFT) (OTCQB: FFRMF) has fully updated and SEO-optimized its e-commerce website (www.LEDCanada.com) in response to rising consumer demand for LED grow lights. The new and expanded site has gone live, and the LED product line can be viewed on LEDCanada.com.

The site now contains a number of social media buttons for Facebook, Twitter, and Pinterest. The LEDCanada.com website will be updated with the newest content from the company, such as blogs, client announcements, newsletters, and specific stories about client successes.

Based in Vancouver, the company is a Canadian LED manufacturer of residential and commercial lighting, fixtures, lamps, and more. It is also a leading indoor plant growth technology company specializing in LED lighting, mobile applications, and vertical farming solutions for the legal cannabis industry.

“Our goal with the updated website is to provide our customers with an easier way to order and learn about Future Farm’s LED grow light services and solutions by allowing them to browse information and order lights based on their own preferences,” William A. Gildea, chairman and chief executive officer of Future Farm, stated in a news release. “The website is now optimized for mobile devices, is interactive, and provides better access to information about LEDCanada.”

For more information, visit www.FutureFarmTech.com